Ioxitalamic Acid

CAS No. 28179-44-4

Ioxitalamic Acid( Telebrix | Vasobrix | Acidum Joxitalamicum )

Catalog No. M27163 CAS No. 28179-44-4

Ioxitalamic Acid is a medical contrast medium and enhances the contrast of structures or fluids in the body in medical imaging.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 107 In Stock
5MG 79 In Stock
10MG 119 In Stock
25MG 197 In Stock
50MG 280 In Stock
100MG 386 In Stock
200MG 510 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Ioxitalamic Acid
  • Note
    Research use only, not for human use.
  • Brief Description
    Ioxitalamic Acid is a medical contrast medium and enhances the contrast of structures or fluids in the body in medical imaging.
  • Description
    Ioxitalamic Acid is a medical contrast medium and enhances the contrast of structures or fluids in the body in medical imaging.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Telebrix | Vasobrix | Acidum Joxitalamicum
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Human Endogenous Metabolite
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    28179-44-4
  • Formula Weight
    643.942
  • Molecular Formula
    C12H11I3N2O5
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    CC(=O)Nc1c(I)c(C(O)=O)c(I)c(C(=O)NCCO)c1I
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Choucair I, et al. Quantification of bile acids: a mass spectrometry platform for studying gut microbe connectionto metabolic diseases. J Lipid Res. 2020 Feb;61(2):159-177.
molnova catalog
related products
  • Propargyl-PEG5-Ms

    Propargyl-PEG5-Ms is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.

  • PAR-3 (1-6) amide (m...

    SFNGGP-NH2 is a biological active peptide. (PAR-3 is a high-affinity thrombin receptor. PAR-3 mRNA is expressed in the cutaneous mast cells of humans. Protease-Activated Receptors (PARs) have been studied for their roles in itch and their itch-associated response through histamine-dependent/independent pathways have been reported. PAR-3 has been shown not to induce itching alone but possibly in conjunction with PAR-4. Co-expression of PAR-3 and PAR-4 enhances thrombin action suggesting that PAR-3 alone does not mediate transmembrane signaling but instead functions as a cofactor to activate PAR-4.)

  • Isoxaflutole

    Isoxaflutole is a low toxic herbicide and has been marketed as a substitute for atrazine.